Envoy Medical, Inc.
COCH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,204 | $30,365 | $27,725 | $30,498 |
| - Cash | $3,556 | $5,287 | $5,312 | $5,483 |
| + Debt | $946 | $901 | $24,029 | $19,661 |
| Enterprise Value | $12,594 | $25,979 | $46,442 | $44,676 |
| Revenue | $42 | $78 | $46 | $42 |
| % Growth | -46.2% | 69.6% | 9.5% | – |
| Gross Profit | -$161 | -$156 | -$180 | -$115 |
| % Margin | -383.3% | -200% | -391.3% | -273.8% |
| EBITDA | -$5,935 | -$4,981 | -$4,442 | -$4,186 |
| % Margin | -14,131% | -6,385.9% | -9,656.5% | -9,966.7% |
| Net Income | -$6,482 | -$5,690 | -$4,998 | -$4,618 |
| % Margin | -15,433.3% | -7,294.9% | -10,865.2% | -10,995.2% |
| EPS Diluted | -0.35 | -0.32 | -0.29 | -0.36 |
| % Growth | -9.4% | -10.3% | 19.4% | – |
| Operating Cash Flow | -$4,331 | -$4,460 | -$3,725 | -$4,388 |
| Capital Expenditures | $0 | -$1 | -$6 | $534 |
| Free Cash Flow | -$4,331 | -$4,461 | -$3,731 | -$3,854 |